From classroom to clinic: Careers in STEM for a healthier future
Join us for our webinar titled "From classroom to clinic: Careers in STEM for a healthier future", which will bring together some of Australia's best and brightest in the health sector
Join us for this free webinar exploring exciting STEM careers in health. In this session, we'll highlight the importance of health in shaping our communities, and showcase the vast array of opportunities available for students passionate about making a difference. From cutting-edge medical research and biotechnology to health data analysis and public health initiatives, the heath technology world offers diverse pathways for growth and impact. Whether you're interested in science, technology, engineering, or mathematics, this webinar will provide insights into how you can shape your career while improving lives. Don’t miss this chance to learn more about the many ways you can contribute to the future of health!
Join us for our free webinar titled "From classroom to clinic – Careers in STEM for a healthier future" which will bring together some of Australia’s best and brightest in the health sector, including Adjunct Professor Craig Rayner FTSE FAHMS, Director of Translational Medicine and Infectious Disease Development at Moderna Australia.
This webinar is the latest in our 2024 Shape Your Future series, an educational initiative from the Australian Academy of Technological Sciences and Engineering (ATSE), which brings experts in science, technology and engineering into Australian classrooms for a virtual chat with students on the things that matter to them.
FREE CAREERS IN STEM WEBINARS — Brought to you by STELR
Shape Your Future webinars show students the different pathways that Australian scientists, engineers & technologists have taken in their careers. To watch previous sessions, visit Shape Your Future webinars
STELR
ATSE’s STEM in schools' education initiative — STELR (Science and Technology Education Leveraging Relevance) — modules include equipment, curriculum resources for classrooms, and teacher support. Teachers can access professional learning sessions as well as online and telephone support.
Speakers
FTSE FAHMS
Adjunct Professor Craig Rayner is a clinical pharmacologist and leading authority in model-informed drug development. He has made key contributions to numerous medicine approvals, including treatments for bacterial infections, influenza and river-blindness, and designed hundreds of clinical trials.
During the Covid-19 pandemic, he provided expert scientific advice to governments, the World Health Organization and NGOs, and led work to debunk and uncover potential Covid-19 interventions.
As inaugural director of Moderna’s Regional Research Centre for Respiratory Medicines and Tropical Diseases (RRC), he helped establish translational, clinical and regulatory science R&D projects and training programs, helping Australia build leading edge capabilities in mRNA science. He currently serves as Director of Translational medicine, Infectious Diseases, a global clinical development role uniquely based in Australia, at the RRC.
Adjunct Professor Rayner bridges seamlessly between the private sector and academia. He built companies to multibillion dollar value, serves on advisory boards, and is adjunct research professor and distinguished alumnus at Monash University.
During the Covid-19 pandemic, he provided expert scientific advice to governments, the World Health Organization and NGOs, and led work to debunk and uncover potential Covid-19 interventions.
As inaugural director of Moderna’s Regional Research Centre for Respiratory Medicines and Tropical Diseases (RRC), he helped establish translational, clinical and regulatory science R&D projects and training programs, helping Australia build leading edge capabilities in mRNA science. He currently serves as Director of Translational medicine, Infectious Diseases, a global clinical development role uniquely based in Australia, at the RRC.
Adjunct Professor Rayner bridges seamlessly between the private sector and academia. He built companies to multibillion dollar value, serves on advisory boards, and is adjunct research professor and distinguished alumnus at Monash University.
Dr Katherine Morgan
IMNIS Catalyst | Bio21 Post doctorate research fellow
IMNIS Catalyst | Bio21 Post doctorate research fellow
Katherine Morgan completed her B.Sc. in 2016 and Master of Science in 2018, both majoring in Chemistry. She completed a Doctor of Philosophy in chemistry at the University of Melbourne in 2023 and has continued her research at Bio21 Molecular Science and Biotechnology Institute.
Her research focuses on designing new personalised molecular treatments for cancer using metallic radionuclides and the development of diagnostic imaging agents for Alzheimer’s Disease. Her research uses a combination of synthetic chemistry, radiochemistry, biochemistry, and cell biology. Teaching undergraduate chemistry laboratory classes was one of the highlights of her time as a postgraduate student and she loves working in the laboratory.
Her research focuses on designing new personalised molecular treatments for cancer using metallic radionuclides and the development of diagnostic imaging agents for Alzheimer’s Disease. Her research uses a combination of synthetic chemistry, radiochemistry, biochemistry, and cell biology. Teaching undergraduate chemistry laboratory classes was one of the highlights of her time as a postgraduate student and she loves working in the laboratory.
Jemima Kang
Elevate Scholar | Health and computing PhD at University of Melbourne
Elevate Scholar | Health and computing PhD at University of Melbourne
Jemima is a first year PhD student at the University of Melbourne in the School of Computing and Information Systems. Her background is in psychology and her PhD focuses on using machine learning and natural language processing techniques to understand how people talk about mental health on social media and how discussions have changed over time.
